Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempest Therapeutics Inc.

6.80
-0.1000-1.45%
Pre-market: 6.78-0.0179-0.26%08:00 EDT
Volume:62.24K
Turnover:429.59K
Market Cap:27.79M
PE:-0.35
High:7.03
Open:7.02
Low:6.75
Close:6.90
Loading ...
Jul 06, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 01, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jun 28, 2021

Major Issues Report

8-K - Current report
Jun 23, 2021

Major Issues Report

8-K - Current report
Jun 11, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 11, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 29, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 15, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 13, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 07, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 29, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Mar 29, 2021

Major Issues Report

8-K - Current report
Mar 29, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Major Issues Report

8-K - Current report